[Insurance and genetics - options to prevent undesirable consequences].
The article analyses the different options to prevent or alleviate the undesirable consequences of molecular genetic information in the sphere of insurance. It distinguishes between macro-, meso- and micro-options. The options are examined in respect of their probability to be realised.
McGleenan
T
T
The Queen's University of Belfast, United Kingdom.
Wiesing
U
U
D003219:Confidentiality / Q000331:legislation & jurisprudence; D005060:Europe; D030342:Genetic Diseases, Inborn / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D030661:Genetic Privacy / Q000331:legislation & jurisprudence*; D005820:Genetic Testing / Q000331:legislation & jurisprudence*; D005858:Germany; D006801:Humans; D007352:Insurance, Life / Q000331:legislation & jurisprudence*; D008967:Molecular Biology / Q000331:legislation & jurisprudence; D009313:National Health Programs / Q000331:legislation & jurisprudence*
Versicherung und Genetik - Optionen zur Verhinderung unerwünschter Auswirkungen.